• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. PROFEMUR MODULAR FEMORAL NECK; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. PROFEMUR MODULAR FEMORAL NECK; HIP COMPONENT Back to Search Results
Model Number PHA0-1252
Device Problems Corroded (1131); Naturally Worn (2988)
Patient Problem No Information (3190)
Event Type  Injury  
Manufacturer Narrative
This complaint will be updated once investigation is complete.Trend will be evaluated.
 
Event Description
Allegedly the patient was revised due to what seems to be taper wear.
 
Manufacturer Narrative
Updated device information, event and evaluation codes.Updated implant date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROFEMUR MODULAR FEMORAL NECK
Type of Device
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key7885021
MDR Text Key120541036
Report Number3010536692-2018-01211
Device Sequence Number1
Product Code LWJ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 05/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model NumberPHA0-1252
Device Catalogue NumberPHA0-1252
Device Lot NumberT10132743
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date09/07/2018
Initial Date Manufacturer Received 09/07/2018
Initial Date FDA Received09/18/2018
Supplement Dates Manufacturer Received09/07/2018
Supplement Dates FDA Received05/28/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-